Lindsey Mangum, PA
Medical · Florence, ALNPI 1861631764
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,713 of the $43,588 with a category attached, or 63.6%. AbbVie accounts for 70.2% of it on its own, with 44 other manufacturers making up the rest. Among medical clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 941 payments — averaging $46.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- UCB, Inc.$1K
- SK Life Science, Inc.$1K
- Biogen$1K
- Pfizer$751
- Lilly USA, LLC$665
- plus $8K from 39 others
What the payments were for
- Speaking & faculty fees$27,71364%
- Travel & lodging$6592%
- Food & beverage$15,19235%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,588 in reported general payments places this provider in the 95th percentile of 175 medical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 103 | $1,226,155 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 71 | $630,164 |
| NuplazidPimavanserin Tartrate | 68 | $325,829 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 42 | $269,419 |
| PanzygaImmun Glob G(Igg)-Ifas/Glycine | 11 | $209,686 |
| Rebif RebidoseInterferon Beta-1a/Albumin | 15 | $157,196 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $109,976 |
| Nurtec OdtRimegepant Sulfate | 56 | $106,118 |
| UbrelvyUbrogepant | 79 | $102,325 |
| FycompaPerampanel | 78 | $89,557 |
| AptiomEslicarbazepine Acetate | 56 | $86,959 |
| Austedo XrDeutetrabenazine | 13 | $82,273 |
| XcopriCenobamate | 63 | $74,948 |
| RytaryCarbidopa/Levodopa | 33 | $62,807 |
| BriviactBrivaracetam | 39 | $56,778 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam, Panzyga, Nurtec Odt | $751 | $945,969138 claims |
| Acadia Pharmaceuticals IncNuplazid | $423 | $325,82968 claims |
| AbbVieUbrelvy, Qulipta | $30,599 | $155,561118 claims |
| UCB, Inc.Briviact, Neupro, Nayzilam | $1,411 | $140,660103 claims |
| Eisai Inc.Fycompa | $224 | $89,55778 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $303 | $86,95956 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $368 | $82,27313 claims |
| SK Life Science, Inc.Xcopri | $1,177 | $74,94863 claims |
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $165 | $66,77184 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $154 | $26,39017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 175 medical providers in Alabama.
Other medical in Florence
- Jaime DunnBirmingham$16K
- Stacy RichersonMobile$12K
- Susannah CashAuburn$11K
- Deana PorterAuburn$9K
- Rachel ThompsonFairhope$9K
- Shelley WinzelerHomewood$8K
- Reiga EvansHuntsville$8K
- Lillian ShafferCullman$8K
- Lauren TidwellHuntsville$8K
- Heidi EssigBirmingham$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.